| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Champions Oncology (NASDAQ:CSBR) is set to give its latest quarterly earnings report on Wednesday, 2024-09-11. Here's what investors need to know before the announcement.
Analysts estimate that Champions Oncology will report an earnings per share (EPS) of $-0.03.
The announcement from Champions Oncology is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
Last quarter the company beat EPS by $0.17, which was followed by a 2.54% increase in the share price the next day.
Here's a look at Champions Oncology's past performance and the resulting price change:
| Quarter | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.16 | -0.15 | -0.17 | -0.10 |
| EPS Actual | 0.01 | -0.16 | -0.15 | -0.16 |
| Price Change % | 3.0% | -3.0% | 5.0% | -1.0% |
Shares of Champions Oncology were trading at $4.23 as of September 06. Over the last 52-week period, shares are down 23.09%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.
To track all earnings releases for Champions Oncology visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: CSBR
